Pharmacologic basis for the treatment of cardiac arrhythmias

Pediatrics. 1975 Jan;55(1):59-67.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Age Factors
  • Anti-Arrhythmia Agents / therapeutic use*
  • Arrhythmias, Cardiac / drug therapy*
  • Arrhythmias, Cardiac / physiopathology
  • Atrioventricular Node / drug effects
  • Child, Preschool
  • Drug Therapy, Combination
  • Half-Life
  • Heart Block / drug therapy
  • Heart Conduction System / drug effects*
  • Heart Conduction System / physiopathology
  • Hemodynamics / drug effects
  • Humans
  • Infant
  • Intestinal Absorption
  • Lidocaine / administration & dosage
  • Lidocaine / adverse effects
  • Lidocaine / metabolism
  • Phenytoin / administration & dosage
  • Phenytoin / adverse effects
  • Phenytoin / metabolism
  • Procainamide / administration & dosage
  • Procainamide / adverse effects
  • Procainamide / metabolism
  • Propranolol / administration & dosage
  • Propranolol / adverse effects
  • Propranolol / metabolism
  • Quinidine / administration & dosage
  • Quinidine / adverse effects
  • Quinidine / metabolism
  • Sinoatrial Node / drug effects

Substances

  • Anti-Arrhythmia Agents
  • Phenytoin
  • Lidocaine
  • Propranolol
  • Quinidine
  • Procainamide